Kawakami Mark 4
4 · Arcadia Biosciences, Inc. · Filed May 12, 2025
Insider Transaction Report
Form 4
Kawakami Mark
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-05-09+12,500→ 33,987 totalExercise: $3.88Exp: 2035-05-09→ Common Stock (12,500 underlying)
Footnotes (1)
- [F1]The options were granted on 5/9/2025 and the vesting occurs as follows, subject to the Participant's continued service: (1) 25% of the shares vest on the first anniversary of the date of the award and (2) 75% of the shares vest in 36 equal installments, the first installment occurring on the last day of the month in which the initial vesting date occurs.